Stealth Mode Biotech Looking for Senior Vice President / Vice President, Head of Portfolio, Pipeline, and Program Management at United States Full Time

Sr. Vice President / Vice President, Head of Portfolio, Pipeline, and Program Management

Ollin Biosciences

Location: Remote (US)

About Us

Ollin is a biotechnology company developing differentiated, impactful therapeutics for the treatment of serious, common ophthalmic diseases. Our approach is to identify, acquire and develop these therapeutic programs with the highest levels of quality, scientific rigor, and transparency. Ollin is targeting biologies that we believe will make meaningful improvements to patient care and treatment outcomes, and we will prospectively utilize the latest technologies in ophthalmic imaging and data sciences to inform our drug development activities.

Working At Ollin

Drug development is always a challenging endeavor. At Ollin, we believe that one of the best things we can do for the patients we aim to serve is to foster a supportive and motivating environment for our team members. To us, this means empowering individuals at all levels of the organization to make smart, informed decisions; creating a safe environment for team members to share their ideas and express their concerns; and, encouraging transparent communication about the challenges faced and overcome daily and the impact the team has on the opportunities entrusted to us.

As an early employee of Ollin, you will help build an ophthalmology-focused, clinical-stage biotechnology company with a highly experienced team. You will have opportunities to take on various roles and responsibilities in an environment that supports and celebrates your professional growth.

Ollin is currently a virtual company. This role may be based in the continental US. Employees of Ollin will be expected to attend in-person workplace gatherings at a common location once to twice per quarter as the company grows.

Role Description:

• We are seeking an accomplished leader who will develop and lead Ollin’s portfolio, pipeline, and program management function. An essential component of this role is to serve as a cross-functional project team leader for Ollin’s lead, clinical-stage program
• This individual will collaborate with senior leaders and other stakeholders to define the lead program’s strategy, oversee operational execution, prioritize development across indications, and evaluate potential partnerships. This highly critical role will lead teams through development, regulatory interactions and submissions, and preparing for commercialization.
• The individual will also collaborate with other Ollin senior leaders and stakeholders to further develop and execute on the company’s portfolio strategy in support of Ollin’s annual goals, corporate mission, and longer-term vision. Working across the organization, the individual will establish governance and decision-making frameworks and drive pipeline and asset prioritization decisions.
• This role will also be responsible for generating key market insights and guiding strategic decisions related to business development, new product planning, and lifecycle management (e.g., label expansions, line extensions, product and device optimization strategies, etc.
• As part of building a company and environment that is both stimulating, adaptable, and high-performing, the ideal candidate will have expertise in assembling resources and building teams that are collaborative and hands-on. In advancing the program’s strategy, this individual will be a figurehead of our patient- and site-centric approach to drug development.
• The successful candidate will champion the lead program’s and portfolio strategies, stay keenly aware of patient and physician needs to identify opportunities within the portfolio and externally, and foster collaboration and best use of resources across the organization.
• This role reports to the Chief Executive Officer.

The Role Includes:

• Develop, maintain and drive Ollin’s portfolio, pipeline, and program management function, to both deliver on Ollin’s lead program’s full potential as well as that of subsequent programs
• Work with company leadership to define the lead program’s strategy and goals and apply their keen business acumen to manage multiple indications, make critical tradeoff decisions, and communicate these decisions to company stakeholders
• Lead and coordinate the program’s core team, create and develop the program strategy and plan
• Integrate the core team’s activities with broader corporate and portfolio strategic initiatives, including planning and articulating timelines and budgets with finance, operations, and company leadership
• Challenge assumptions, timelines and expenses at the program level; pressure test plans; and create alternative scenarios to enable strategic and operational agility
• Identify bottlenecks, surface issues, and proactively drive towards resolution of these challenges
• Maintain strategic leadership of key documents in support of regulatory submissions and clinical documents
• Participate in analyzing and interpreting clinical data together with clinical science and biometrics colleagues, and clearly communicate results both internally and externally
• As needed, act as a spokesperson for the program and represent the program internally and externally
• Drive development of company’s portfolio strategy and gain alignment across the organization to execute on the strategy
• Implement governance and decision-making frameworks and processes to enable effective decision making and oversight across Ollin’s portfolio
• Develop and track key performance indicators (KPIs) and metrics to track portfolio and project performance against strategic goals and objectives
• Stay abreast of and evaluate opportunities for potential partnership for programs across Ollin’s portfolio
• Anticipate internal and external drivers of change, including Ollin program development, developments made by competitive programs, and evolution of the regulatory landscape, to guide portfolio strategy and new product planning

Requirements:

• MD, PhD or MD/PhD with demonstrated experience developing antibody therapeutics in early and late-stage clinical trials; experience leading ophthalmology / retina programs is a plus
• Alternatively, BA/BS in a relevant scientific field plus MBA, with demonstrated cross-functional business leadership experience in ophthalmology/retina; in this case, experience working on pre-approval programs is necessar
• Proven track record of operational execution in one or more core areas of drug development and/or commercialization
• Proven track record of cross-functional team leadership experience
• Proven track record of direct people leadership, including hiring, managing, and mentoring direct reports
• Expertise in successful drug development and/or commercialization with at least 10 years of industry experience
• Strong decision-making skills and highly organized
• Excellent leadership skills and proven ability to effectively work in a cross-functional environment
• An innate approach that is centered on integrity, collaboration, and organization